Nasus Pharma Ltd (NSRX) stock
Close on Nov 13, 2026Market cap $25.87MP/E –Yield –
Nasus Pharma statistics
67 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 2.35
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 0.01
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 14.0%
- 10.8%
- Float
- 4M
- 49M
- Shares Held by Insiders
- 59.3%
- 11.7%
- Shares Held by Institutions
- 23.9%
- 56.4%
Short sellingIndustry
- Short Interest
- 71,005
- –
- Short Interest Change
- -11.7%
- -0.80%
- Short % of Float
- 1.93%
- 9.01%
- Short % of Shares Outstanding
- 0.79%
- 6.30%
- Days to Cover
- 3.65
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $9.50
- –
- 52-Week Low
- $1.98
- –
- 20-Day Moving Average
- $3.11
- –
- 50-Day Moving Average
- $3.37
- –
- 200-Day Moving Average
- $3.47
- –
- Average True Range (14)
- $0.24
- –
- Price Change (1 Week)
- 1.77%
- -1.15%
- Price Change (1 Month)
- -9.32%
- -4.87%
- Price Change (3 Months)
- -22.4%
- -21.0%
- Price Change (6 Months)
- -0.69%
- -20.6%
- Price Change (YTD)
- -68.6%
- -23.6%
- Price Change (1 Year)
- -62.2%
- -22.4%
- Average Volume (10 Days)
- 13,925
- –
- Average Volume (20 Days)
- 16,904
- –
- Average Volume (90 Days)
- 16,269
- –
- Relative Volume
- 0.28
- 0.70
- Relative Strength Index (14)
- 38.5
- 43.4
- Volatility (1 Year)
- 101.8%
- 80.1%
MarginsIndustry
- EBITDA Margin
- -0.40%
- -27.7%
- FCF Margin
- -0.40%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -175.3%
- -49.9%
- Return on Assets (ROA)
- -89.5%
- -40.6%
- Return on Capital Employed (ROCE)
- -44.4%
- -37.9%
Financial positionIndustry
- Current Ratio
- 8.77
- 3.30
- Quick Ratio
- 5.57
- 2.39
EfficiencyIndustry
- Asset Turnover
- 188.72
- 0.40
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $7.82M
- $17.76M
- Net Cash Per Share
- $0.87
- $0.80
- Equity (Book Value)
- $11.00M
- $53.89M
- Book Value Per Share
- $1.22
- $1.50
- Tangible Book Value
- $11.00M
- $27.13M
- Working Capital
- $10.91M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$14.00K
- -$1.00M
- FCF Per Share
- -$0.55
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -22.6%
- -21.8%
- FCF Yield
- -19.1%
- -9.44%
- Buyback Yield
- -32.8%
- -0.76%
- Shareholder Yield
- -32.8%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- -$78.00K
- $2.90M
Scores and fair valueIndustry
- Altman Z-Score
- 106.89
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | NSRX | S&P 500 | Difference | NSRX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -9.2% | -3.0% | −6.1 pts | ||
| 3 months | -10.3% | -2.8% | −7.5 pts | ||
| Year to date | -68.6% | +11.5% | −80.1 pts | ||
| 1 year | -63.7% | +13.5% | −77.1 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M NSRX shares were sold short on Oct 30, 2026, down 11.7% from the previous report, or 1.93% of the shares available to trade. At recent volumes it would take 3.6 days to buy them back. Over the last 20 sessions, 47.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 71,005 | -11.7% | 19,443 | 3.6 |
| Oct 15, 2026 | 80,432 | +2.8% | 17,163 | 4.7 |
| Sep 30, 2026 | 78,238 | -2.8% | 27,246 | 2.9 |
| Sep 15, 2026 | 80,533 | -7.7% | 10,116 | 8.0 |
| Aug 31, 2026 | 87,272 | -39.6% | 14,783 | 5.9 |
| Aug 14, 2026 | 144,506 | -9.7% | 17,670 | 8.2 |
| Jul 31, 2026 | 160,076 | -6.2% | 10,559 | 15.2 |
| Jul 15, 2026 | 170,667 | -0.9% | 14,454 | 11.8 |
| Jun 30, 2026 | 172,140 | -3.0% | 25,001 | 6.9 |
| Jun 15, 2026 | 177,466 | +2.9% | 42,908 | 4.1 |
| May 29, 2026 | 172,484 | +11.3% | 55,723 | 3.1 |
| May 15, 2026 | 155,032 | +39.6% | 72,447 | 2.1 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?